Novo Nordisk buys new priority review voucher for FDA

Novo Nordisk has purchased a priority review voucher that ensures the company a quicker review of an application to FDA. The seller is an Australian company.

Photo: Linda Kastrup / Ritzau Scanpix

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles